Yahoo
OTC Markets OTCPK - Delayed Quote USD

Coloplast A/S (CLPBY)

7.24 +0.04 (+0.56%)
At close: October 30 at 4:00:00 PM EDT
Chart Range Bar
Loading chart for CLPBY
  • Previous Close 7.20
  • Open 7.32
  • Bid 7.25 x 151700
  • Ask 7.28 x 265000
  • Day's Range 7.24 - 7.32
  • 52 Week Range 5.64 - 9.70
  • Volume 6,281
  • Avg. Volume 202,801
  • Market Cap (intraday) 16.317B
  • Beta (5Y Monthly) 0.56
  • PE Ratio (TTM) 38.11
  • EPS (TTM) 0.19
  • Earnings Date --
  • Forward Dividend & Yield 0.36 (4.97%)
  • 1y Target Est 8.33
  • Zacks Rating Bearish

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; Peristeen Plus, a transanal irrigation system; and Peristeen Light, a low-volume transanal irrigation. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as erectile dysfunction, urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.

www.coloplast.com

17,213

Full Time Employees

September 30

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is OMX Copenhagen 25 Index (^OMXC25) .

YTD Return

CLPBY
13.79%
OMX Copenhagen 25 Index (^OMXC25)
0.00%

1-Year Return

CLPBY
19.65%
OMX Copenhagen 25 Index (^OMXC25)
16.87%

3-Year Return

CLPBY
26.63%
OMX Copenhagen 25 Index (^OMXC25)
23.23%

5-Year Return

CLPBY
50.61%
OMX Copenhagen 25 Index (^OMXC25)
0.16%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue 7.36B
Earnings 1.46B
Profit Margin 19.88%

Q4

FY25

Q1

FY26

Q2

FY26

Q3

FY26

0
2B
4B
6B
-10.0%
0.0%
10.0%

Analyst Insights

View More

Analyst Price Targets

6.70
8.33 Average
7.24 Current
12.20 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    9.71%

  • Return on Assets (ttm)

    10.12%

  • Return on Equity (ttm)

    18.53%

  • Revenue (ttm)

    28.44B

  • Net Income Avi to Common (ttm)

    2.76B

  • Diluted EPS (ttm)

    0.19

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    817M

  • Total Debt/Equity (mrq)

    178.07%

  • Levered Free Cash Flow (ttm)

    4.67B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: